Diabetic Neuropathy Recommendations
Screening
| "1. All patients should be assessed for diabetic peripheral neuropathy starting at diagnosis of type 2 di- abetes and 5 years after the diag- nosis of type 1 diabetes and at least annually thereafter. (Level of Evidence: B)" |
| "2. Assessment should include a careful history and 10-g monofilament testing and at least one of the following tests: pinprick, temperature, or vibration sensation. (Level of Evidence: B)" |
| "3.Symptoms and signs of autonomic neuropathy should be assessed in patients with microvascular and neuropathic complications. (Level of Evidence: E)" |
Treatment
| "1. Optimize glucose control to pre- vent or delay the development of neuropathy in patients with type 1 diabetes A and to slow the pro- gression of neuropathy in patients with type 2 diabetes. (Level of Evidence: B)" |
| "2. Assess and treat patients to reduce pain related to diabetic peripheral neuropathy B and symptoms of au- tonomic neuropathy and to im- prove quality of life. (Level of Evidence: E)" |